Tynicare is an innovative company developing in-vitro organ system for disease modelling, drug testing and other biological research

The platform has a more realistic representation of human physiology, of organs such as brain, heart, liver, kidney etc. than traditional cell culture methods and help to reduce or replace the use of animal testing, providing a faster, cheaper, and more accurate alternative for drug discovery and development.